Suppr超能文献

对于接受放射治疗的转移性脊髓压迫患者,治疗后功能结果的改善与更好的生存率相关。

Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression.

作者信息

Rades Dirk, Veninga Theo, Stalpers Lukas J A, Basic Hiba, Hoskin Peter J, Karstens Johann H, Schild Steven E, Dunst Juergen

机构信息

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Lübeck, Germany.

出版信息

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1506-9. doi: 10.1016/j.ijrobp.2006.11.029. Epub 2007 Feb 1.

Abstract

PURPOSE

To evaluate the potential prognostic impact of the effect of radiotherapy (RT) on motor function and of the post-RT ambulatory status on survival in metastatic spinal cord compression (MSCC) patients.

METHODS AND MATERIALS

Of 1,852 patients irradiated for MSCC, 778 patients (42%) received short-course RT and 1,074 (58%) received long-course RT. The effect of RT on motor function (improvement vs. no change vs. deterioration) and the ambulatory status after RT (ambulatory vs. nonambulatory) were evaluated with respect to survival.

RESULTS

The actuarial survival rate of the entire cohort was 56% at 6 months, 43% at 12 months, and 32% at 24 months. The patients in whom motor function improved after RT had a significantly better 1-year survival rate than those who had no change or deterioration of motor function (75% vs. 40% and 3%, p < 0.001). The 1-year survival rate of the patients who were ambulatory after RT was significantly better than for those who were not ambulatory (63% vs. 4%, p < 0.001). The results were confirmed in multivariate analysis.

CONCLUSIONS

The response to RT and the post-RT ambulatory status are important predictors for survival in MSCC patients. This finding can be used by physicians to stratify future studies, plan further therapy, and improve follow-up strategy in these patients.

摘要

目的

评估放射治疗(RT)对运动功能的影响以及放疗后步行状态对转移性脊髓压迫(MSCC)患者生存的潜在预后影响。

方法和材料

在1852例接受MSCC放疗的患者中,778例(42%)接受短程放疗,1074例(58%)接受长程放疗。评估RT对运动功能的影响(改善、无变化、恶化)以及放疗后的步行状态(可步行、不可步行)与生存的关系。

结果

整个队列的精算生存率在6个月时为56%,12个月时为43%,24个月时为32%。放疗后运动功能改善的患者1年生存率明显高于运动功能无变化或恶化的患者(75%对40%和3%,p<0.001)。放疗后可步行的患者1年生存率明显高于不可步行的患者(63%对4%,p<0.001)。多因素分析证实了这些结果。

结论

对放疗的反应和放疗后的步行状态是MSCC患者生存的重要预测因素。这一发现可供医生用于对未来研究进行分层、规划进一步治疗以及改善这些患者的随访策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验